Oxybutynin Chloride Tablet
Product Images NDC 68788-8141

8 FDA label images from Preferred Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 68788-8141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Figure 1 Structure)

Structural Formula (Figure 1 Structure)
Chemical structure diagram of oxybutynin chloride, depicting its molecular arrangement with labeled connected atoms and bonds.*
FDA Label Image

Table 1 (Figure 2 Table1)

Table 1 (Figure 2 Table1)
A data table displaying pharmacokinetic parameters for R-Oxybutynin and S-Oxybutynin. It lists values for Cmax (ng/mL), Tmax (h), AUCt (ng·h/mL), and AUCinf (ng·h/mL), with associated mean and standard deviation values for each isomer.*
FDA Label Image

Figure 1 (Figure 3 Figure1)

Figure 1 (Figure 3 Figure1)
A line graph showing the mean plasma concentration of oxybutynin 5 mg over a 24-hour period. The x-axis represents time in hours, while the y-axis shows mean plasma oxybutynin concentration in ng/mL. Data points are marked at intervals with error bars indicating variability in concentration.*
FDA Label Image

Table 2 (Figure 4 Table2)

Table 2 (Figure 4 Table2)
A data table presenting pharmacokinetic parameters including Cmax, Tmax, and AUC for R-Oxybutynin, S-Oxybutynin, R-Desethyloxybutynin, and S-Desethyloxybutynin. Values are shown with means and standard deviations, reflecting pooled data for these compounds.*
FDA Label Image

Figure 2 (Figure 5 Figure2)

Figure 2 (Figure 5 Figure2)
A line graph illustrating the mean plasma concentration of R-Oxybutynin (ng/mL) over time (hours). The graph shows data points with error bars at intervals from 0 to 12 hours, indicating concentration changes after dosing.*
FDA Label Image

Table 3 (Figure 6 Table3)

Table 3 (Figure 6 Table3)
A data table showing adverse events reported in patients taking Oxybutynin Chloride (5-20 mg/day). The table categorizes events by body system, such as Infections and Infestations, Psychiatric Disorders, Nervous System Disorders, Eye Disorders, Gastrointestinal Disorders, and Renal and Urinary Disorders, listing specific adverse events and their corresponding percentages.*
FDA Label Image
Kvk Logo (Figure 7 Company Logo)
FDA Label Image

Oxybutynin Chloride Tablets Usp 5mg (Figure 8 100s Label)

Oxybutynin Chloride Tablets Usp 5mg (Figure 8 100s Label)
Label for Oxybutynin Chloride Tablets USP 5 mg oral tablets, generic for Ditropan, labeled by Preferred Pharmaceuticals Inc. It includes storage instructions, manufacturer details (KVK-Tech, Inc.), and warnings. Directions are provided in English and Spanish, with placeholders for dosage frequency. The label also features barcode and batch information fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.